Thioperamide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| N-Cyclohexyl-4-(1H-imidazol-4-yl)piperidine-1-carbothioamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 106243-16-7 |
| ATC code | None |
| PubChem | CID 3035905 |
| IUPHAR ligand | 1267 |
| ChemSpider | 2300031 |
| ChEMBL | CHEMBL260374 |
| Chemical data | |
| Formula | C15H24N4S |
| Mol. mass | 292.44 g/mol |
|
|
|
|
| |
Thioperamide is a potent and selective histamine H3 antagonist that is capable of crossing the blood–brain barrier. Thioperamide was used by Jean-Charles Schwartz in his early experiments regarding the H3 receptor.[1][1] Thioperamide was found to be an antagonist of histamine autoreceptors, which detect the presence of histamine. Thioperamide enhances the activity of histaminergic neurons by blocking autoreceptors, thus preventing the detection of histamine by neurons. This causes the neurons to release more histamine, thus increasing their activity.
See also[edit]
References[edit]
- ^ Schwartz, Jean-Charles. The histamine H3 receptor: from discovery to clinical trials with pitolisant. BPJ 2011 May
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

